4
Changes in Ownership
Inmune Bio, Inc. Filed Acc 0001213900-21-045373
President and CEO acquired 30,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Tesi Raymond Joseph · President and CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-08-25 | Exercise or conversion : show line 1 in the form | +30,000 | $3.91 | $117,300 | 1,524,433 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-08-25 | Exercise or conversion : show line 2 in the form Employee Stock Option (right to buy) | −30,000 | 270,000 | D |
Loading xslF345X03/ownership.xml…